How we do

  We are developing efficient gene delivery technology to subcutaneous fat, particularly adipocytes, without using virus. Unlike virus, our therapy will be non-immunogenic and very safe.

In addition, drug price can be a “sustainable” level because its manufacturing is  far simpler than viral one.  Subcutaneous fat targeted gene therapies can be applicable to wide range of diseases.

What makes us unique is our proprietary human adipose tissue culture technology.  This  can make clinical efficacy and safety highly predictable.